FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977761524> ?p ?o ?g. }

• W2977761524 abstract "Abstract Background There is a need for additional treatment options in refractory JIA uveitis which has responded inadequately to MTX and anti TNFα. There has been interest in the use of tocilizumab, the APTITUDE trial using SC tocilizumab in JIA uveitis and the STOP-Uveitis study comparing 2 dosing regimens of iv tocilizumab in adults. Anecdotal evidence reports JIA uveitis patients who were stable on IV tocilizumab flaring when switched to sc administration. We describe the successful use of IV tocilizumab and concurrent sc MTX in two cases. Methods Retrospective review of patient paper and electronic medical records. Results Case 1.: A five-year-old female presented with severe anterior uveitis in her right eye. She was diagnosed with idiopathic uveitis and treated with topical steroid, oral then SC MTX infliximab, mycophenolate and adalimumab, all with inadequate control of her uveitis. At the age of 12, on adalimumab, she developed arthritis and her diagnosis was changed to JIA uveitis. 7 years after initial diagnosis she was commenced on IV tocilizumab 8mgs/kg 4-weekly with improved control of her uveitis although initially still requiring some topical steroid. She required intra-articular steroids for active arthritis and agreed to restart SC MTX. On tocilizumab and MTX combined, her arthritis settled and her topical eye drops were weaned for the first time since diagnosis. From age 5 until 14 she was continually on topical steroids, consequently developing raised intraocular pressure and a dense cataract. With improved disease control she had cataract surgery aged 14. She has maintained good disease control for the last five years on the combination of IV tocilizumab and SC MTX and has not required any further steroids. Case 2: A 3 year old female with oligoarticular JIA had severe bilateral uveitis at presentation. Initial treatment was with oral prednisolone, topical steroid and SC MTX. 6 months after diagnosis her uveitis remained active and she was commenced on infliximab with additional IV methylprednisolone. Venous access was challenging, required a portacath to facilitate treatment. By the age of 6 she had developed a cataract requiring surgery and still had incomplete control of her uveitis. Infliximab was increased to 10mgs/kg 4 weekly with little further benefit and at the age of 7 she was changed to adalimumab. On this she developed macular oedema requiring pulse IV methylprednisolone. 5 years after diagnosis she was commenced on IV tocilizimab initially 4 weekly, increasing after three months to 2 weekly. Her methylprednisolone was weaned and she has subsequently maintained good disease control on IV tocilizumab 10mgs/kg 2 weekly with SC methotrexate. Conclusion We describe two cases of refractory JIA and uveitis in whom IV tocilizumab with SC methotrexate has provided good disease control. Further studies are required to determine the optimal dosing regimen. Conflicts of Interest The authors declare no conflicts of interest." @default.
• W2977761524 created "2019-10-10" @default.
• W2977761524 creator A5005261639 @default.
• W2977761524 creator A5007382763 @default.
• W2977761524 creator A5009261265 @default.
• W2977761524 creator A5062965111 @default.
• W2977761524 creator A5081594689 @default.
• W2977761524 date "2019-09-30" @default.
• W2977761524 modified "2023-09-24" @default.
• W2977761524 title "P47 Successful treatment of two cases of refractory JIA uveitis with intravenous tocilizumab and subcutaneous methotrexate" @default.
• W2977761524 doi "https://doi.org/10.1093/rheumatology/kez416.014" @default.
• W2977761524 hasPublicationYear "2019" @default.
• W2977761524 type Work @default.
• W2977761524 sameAs 2977761524 @default.
• W2977761524 citedByCount "0" @default.
• W2977761524 crossrefType "journal-article" @default.
• W2977761524 hasAuthorship W2977761524A5005261639 @default.
• W2977761524 hasAuthorship W2977761524A5007382763 @default.
• W2977761524 hasAuthorship W2977761524A5009261265 @default.
• W2977761524 hasAuthorship W2977761524A5062965111 @default.
• W2977761524 hasAuthorship W2977761524A5081594689 @default.
• W2977761524 hasBestOaLocation W29777615241 @default.
• W2977761524 hasConcept C118487528 @default.
• W2977761524 hasConcept C121332964 @default.
• W2977761524 hasConcept C126322002 @default.
• W2977761524 hasConcept C141071460 @default.
• W2977761524 hasConcept C142424586 @default.
• W2977761524 hasConcept C2776194053 @default.
• W2977761524 hasConcept C2777178219 @default.
• W2977761524 hasConcept C2777575956 @default.
• W2977761524 hasConcept C2781059491 @default.
• W2977761524 hasConcept C71924100 @default.
• W2977761524 hasConcept C87355193 @default.
• W2977761524 hasConceptScore W2977761524C118487528 @default.
• W2977761524 hasConceptScore W2977761524C121332964 @default.
• W2977761524 hasConceptScore W2977761524C126322002 @default.
• W2977761524 hasConceptScore W2977761524C141071460 @default.
• W2977761524 hasConceptScore W2977761524C142424586 @default.
• W2977761524 hasConceptScore W2977761524C2776194053 @default.
• W2977761524 hasConceptScore W2977761524C2777178219 @default.
• W2977761524 hasConceptScore W2977761524C2777575956 @default.
• W2977761524 hasConceptScore W2977761524C2781059491 @default.
• W2977761524 hasConceptScore W2977761524C71924100 @default.
• W2977761524 hasConceptScore W2977761524C87355193 @default.
• W2977761524 hasLocation W29777615241 @default.
• W2977761524 hasOpenAccess W2977761524 @default.
• W2977761524 hasPrimaryLocation W29777615241 @default.
• W2977761524 hasRelatedWork W1480215067 @default.
• W2977761524 hasRelatedWork W2081562444 @default.
• W2977761524 hasRelatedWork W2097741071 @default.
• W2977761524 hasRelatedWork W2109686163 @default.
• W2977761524 hasRelatedWork W2127133939 @default.
• W2977761524 hasRelatedWork W2133321705 @default.
• W2977761524 hasRelatedWork W2331909567 @default.
• W2977761524 hasRelatedWork W2332852477 @default.
• W2977761524 hasRelatedWork W2476550218 @default.
• W2977761524 hasRelatedWork W2582422567 @default.
• W2977761524 hasRelatedWork W2608839610 @default.
• W2977761524 hasRelatedWork W2765271240 @default.
• W2977761524 hasRelatedWork W2788531276 @default.
• W2977761524 hasRelatedWork W2944349252 @default.
• W2977761524 hasRelatedWork W2951912926 @default.
• W2977761524 hasRelatedWork W2959305462 @default.
• W2977761524 hasRelatedWork W2995042878 @default.
• W2977761524 hasRelatedWork W3032768597 @default.
• W2977761524 hasRelatedWork W3048704141 @default.
• W2977761524 hasRelatedWork W3089633195 @default.
• W2977761524 isParatext "false" @default.
• W2977761524 isRetracted "false" @default.
• W2977761524 magId "2977761524" @default.
• W2977761524 workType "article" @default.